Suzhou LMBIO

Suzhou LMBIO is a biotechnology company based in Suzhou, China, specializing in the discovery and development of innovative small molecule and biologic therapeutics. The company operates as both a drug developer and a contract research organization (CRO), providing integrated services in medicinal chemistry, pharmacology, and early-stage drug discovery. Suzhou LMBIO focuses on high-impact therapeutic areas including metabolic diseases, oncology, and inflammatory disorders. By leveraging its proprietary technology platforms, the company aims to accelerate the transition of novel candidates from lead optimization to clinical development.